Select Presentations from the 2016 Lung Transplant Conference: Part One

In part one of Select Presentations from the 2016 Lung Transplant Conference, Ms. Lisa Carozza, and Drs. Matthew Pipeling, and Silpa Kilaru join together to discuss various topics in the transplant evaluation process. 

Educational objectives: 

Upon completion of this activity, participants should be able to:

• Improve management of pre-transplant medical record review, to provide high-quality pre-transplant planning to patients in all areas of their life.
• Improve practitioner skill in knowing when the diagnosis indicates lung transplantation is a viable surgical option for treatment.
• Recognize the importance of relative and absolute contra-indications, to make smarter decisions about recipient-donor match.
• Shed light on new clinical possibilities in lung transplantation, to encourage other capable centers of considering what was once considered impossible.
• Provide knowledge of ways UPMC is pushing the candidate selection envelope, in order to provide hope to patients who may not have been able to be treated at other centers.
• Increase knowledge of the feasibility and success rates in utilizing lung transplant as an option to treat scleroderma patients with end-stage lung diseases.
• Improve awareness of the scleroderma mortality rates patients are faced with.

Reading Resources:

1. Patient factors associated with lung transplant referral and waitlist for patients with cystic fibrosis and pulmonary fibrosis. Yuan Liu, Monica Vela, Tanya Rudakevych, Christopher Wigfield, Edward Garrity, Milda R. Saunders. Publication stage: In Press Corrected Proof. The Journal of Heart and Lung Transplantation. Published online: August 21, 2016 
2. 592: Coping, Psychological Functioning, and Quality of Life among Patients Being Evaluated for Lung Transplantation. M.R. Green, C.F. Emery, P. Ross, S.D. Moffatt-Bruce, A.L. Pope-Harman, D. Nunley, R. Long, A. Heilman. The Journal of Heart and Lung Transplantation, Vol. 28, Issue 2, S271. Published in issue: February 2009
3. A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. David Weill, Christian Benden, Paul A. Corris, John H. Dark, R. Duane Davis, Shaf Keshavjee, David J. Lederer, Michael J. Mulligan, and others. The Journal of Heart and Lung Transplantation, Vol. 34, Issue 1, p1–15. Published online: June 26, 2014
4. Successful Double Lung Transplantation in 2 Patients With Severe Scoliosis. Jang Wen Su, David P. Mason, Sudish C. Murthy, Marie M. Budev, Atul C. Mehta, Ryan Goodwin, Gosta B. Pettersson. The Journal of Heart and Lung Transplantation, Vol. 27, Issue 11, p1262–1264. Published in issue: November 2008
5. Impact of donor and recipient hepatitis C status in lung transplantation. Brian R. Englum, Asvin M. Ganapathi, Paul J. Speicher, Brian C. Gulack, Laurie D. Snyder, R. Duane Davis, Matthew G. Hartwig. The Journal of Heart and Lung. Transplantation, Vol. 35, Issue 2, p228–235. Published online: October 8, 2015 
6. Donor-Recipient Size Mismatch in Lung Transplantation Does Not Negatively Impact Survival: An Review of the UNOS Database. G.J. Bittle, Z.N. Kon, P.G. Sanchez, A.C.. Watkins, B.P. Griffith. The Journal of Heart and Lung Transplantation, Vol. 32, Issue 4, S122–S123. Published in issue: April 2013
7. Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies. Volkmann ER, Tashkin DP. Ann Am Thorac Soc. 2016 Nov;13(11):2045-2056.
8. Lung Transplantation in Scleroderma. Time for the Pendulum to Swing? Eberlein M, Mathai SC. Ann Am Thorac Soc. 2016 Jun;13(6):767-9. doi: 10.1513/AnnalsATS.201512-801ED.
9. Lung Transplant Outcomes in Systemic Sclerosis with Significant Esophageal Dysfunction. A Comprehensive Single-Center Experience. Miele CH, Schwab K, Saggar R, Duffy E, Elashoff D, Tseng CH, Weigt S, Charan D, Abtin F, Johannes J, Derhovanessian A, Conklin J, Ghassemi K, Khanna D, Siddiqui O, Ardehali A, Hunter C, Kwon M, Biniwale R, Lo M, Volkmann E, Torres Barba D, Belperio JA, Sayah D, Mahrer T, Furst DE, Kafaja S, Clements P, Shino M, Gregson A, Kubak B, Lynch JP 3rd, Ross D, Saggar R. Ann Am Thorac Soc. 2016 Jun;13(6):793-802. doi: 10.1513/AnnalsATS.201512-806OC.

Disclosures:

Drs.  Carozza, Pipeling, and Kilaru have reported no relevant relationships with any entities producing health care goods or services.

All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above.  No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement:

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.125) continuing education units (CEU) which are equivalent to 1.25 contact hour.

For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.edu and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.

Release Date: 6/20/2017 | Last Modified On: 6/20/2017 | Expires: 6/20/2018